Publications by authors named "Peter Keck"

Claim this Profile
C
Cardiac preservation using organ perfusion: new therapies for the treatment of heart failure by harnessing the power of growth factors using BMP mimetics like THR-184.
William D Carlson, Dattatreyamurty Bosukonda, Peter C Keck, Philippe Bey, Shannon N Tessier

Front Cardiovasc Med· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Process for the Design and Development of Novel Bone Morphogenetic Protein-7 (BMP-7) Mimetics With an Example: THR-184.
William D Carlson, Peter C Keck, Dattatreyamurty Bosukonda, Frederic Roy Carlson

Front Pharmacol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiorgan Damage in Patients With COVID-19: Is the TGF-/BMP Pathway the Missing Link?
F Roy Carlson, Dattatreyamurty Bosukonda, Peter C Keck, William D Carlson

JACC Basic Transl Sci· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A p38 substrate-specific MK2-EGFP translocation assay for identification and validation of new p38 inhibitors in living cells: a comprising alternative for acquisition of cellular p38 inhibition data.
Roman Anton, Silke M Bauer, Peter R W E F Keck, Stefan Laufer, Ulrich Rothbauer

PLoS One· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2-(3-{(3R,4R)-4-Methyl-3-[meth-yl(7H-pyrrolo-[2,3-d]pyrimidin-4-yl)amino]-piperidin-1-yl}oxetan-3-yl)aceto-nitrile monohydrate.
Matthias Gehringer, Ellen Pfaffenrot, Peter R W E F Keck, Dieter Schollmeyer, Stefan A Laufer

Acta Crystallogr Sect E Struct Rep Online· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to Regarding the mechanism of action of a proposed peptide agonist of the bone morphogenetic protein receptor activin-like kinase 3.
Hikaru Sugimoto, Valerie S LeBleu, Dattatreyamurty Bosukonda, Peter Keck, Gangadhar Taduri

Nat Med· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2-[5-Bromo-1-(3-chloro-benz-yl)-2-methyl-1H-indol-3-yl]acetic acid.
Mahmoud Elkady, Peter R W E F Keck, Dieter Schollmeyer, Stefan Laufer

Acta Crystallogr Sect E Struct Rep Online· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
3
3-(4-Bromo-phen-yl)-1-phenyl-1H-pyrazole-4-carbaldehyde.
Mahmoud Elkady, Peter R W E F Keck, Dieter Schollmeyer, Stefan Laufer

Acta Crystallogr Sect E Struct Rep Online· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activin-like kinase 3 is important for kidney regeneration and reversal of fibrosis.
Hikaru Sugimoto, Valerie S LeBleu, Dattatreyamurty Bosukonda, Peter Keck, Gangadhar Taduri

Nat Med· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
6
6-(4-Chloro-phen-yl)-7-phenyl-2,3-dihydro-1H-pyrrolizine-5-carbaldehyde.
Peter R W E F Keck, Dieter Schollmeyer, Stefan Laufer

Acta Crystallogr Sect E Struct Rep Online· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
6
6-(4-Meth-oxy-phen-yl)-7-phenyl-2,3-dihydro-1H-pyrrolizine-5-carbaldehyde.
Peter R W E F Keck, Dieter Schollmeyer, Stefan Laufer

Acta Crystallogr Sect E Struct Rep Online· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Arylpyrrolizines as inhibitors of microsomal prostaglandin E2 synthase-1 (mPGES-1) or as dual inhibitors of mPGES-1 and 5-lipoxygenase (5-LOX).
Andy J Liedtke, Peter R W E F Keck, Frank Lehmann, Andreas Koeberle, Oliver Werz

J Med Chem· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis